2025-07-29
Graves’ Disease Gut Microbiome Signature: Key Genera and Clinical ImplicationsThis prospective study identifies a unique gut microbiome signature in Graves’ disease, characterized by decreased SCFA-producing bacteria and increased pro-inflammatory taxa, which partially recovers with antithyroid therapy. Twelve genera robustly distinguish GD, offering potential for early diagnosis and microbiome-targeted interventions.